Vertex Pharmaceuticals Inc (VRTX)

186.56 +1.07  +0.58% NASDAQ Oct 21, 13:07 USD
View Full Chart
Price Chart
View All VRTX News

News

View All Events

Events

Date Type Description
10/29/2021 Earnings Results Q3 2021 Earnings Results
10/29/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
07/29/2021 Earnings Results Q2 2021 Earnings Results
07/29/2021 17:30 EST Earnings Calls Q2 2021 Earnings Call
05/19/2021 09:30 EST AGM 2021 Annual General Meeting
04/29/2021 Earnings Results Q1 2021 Earnings Results
04/29/2021 17:30 EST Earnings Calls Q1 2021 Earnings Call
02/01/2021 Earnings Results Q4 2020 Earnings Results
02/01/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
10/29/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex’s pipeline includes gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease as well as small-molecule medicines targeting diseases associated with alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease. Vertex also has an expanding research pipeline focused on inflammatory diseases, non-opioid treatments for pain, and genetic and cell therapies for type 1 diabetes and rare diseases.
  • URL: https://www.vrtx.com
  • Investor Relations URL: https://investors.vrtx.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Oct. 29, 2021
  • Last Earnings Release: Jul. 29, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
BBH VanEck Biotech ETF 5.35%
HQL Tekla Life Sciences Investors 4.47%
LMPFX ClearBridge Aggressive Growth FI 4.27%
IBB iShares Biotechnology ETF 3.83%
ARKG ARK Genomic Revolution ETF 3.69%
HQH Tekla Healthcare Investors 3.58%
FBT First Trust NYSE Arca Biotech ETF 3.42%
AMRBX American Growth One B 2.35%
LGRCX Loomis Sayles Growth C 2.28%
ABPRX AB Large Cap Growth R 2.24%
VGHCX Vanguard Health Care Inv 1.85%
PRHSX T. Rowe Price Health Sciences 1.47%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.